This page shows the publications co-authored by Eric Wong and Kenneth Swanson.
Wong ET, Swanson KD. Dexamethasone-Friend or Foe for Patients With Glioblastoma? JAMA Neurol. 2019 03 01; 76(3):247-248.
Wong ET, Lok E, Swanson KD. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality. Prog Neurol Surg. 2018; 32:180-195.
Wong ET, Swanson KD. Everolimus shortens survival of newly diagnosed glioblastoma patients. J Neurooncol. 2018 Oct; 140(1):179-180.
Swanson KD, Lok E, Wong ET. An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma. Curr Neurol Neurosci Rep. 2016 Jan; 16(1):8.
Wong ET, Swanson KD. Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'. Br J Cancer. 2015 Dec 01; 113(11):1633-4.
Wong ET, Lok E, Swanson KD. An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas. Curr Treat Options Oncol. 2015 Aug; 16(8):40.
Wong ET, Lok E, Swanson KD. Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation. Cancer Med. 2015 Mar; 4(3):383-91.
Riley MM, San P, Lok E, Swanson KD, Wong ET. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma. J Vis Exp. 2019 04 16; (146).
Timmons JJ, Zhang K, Fong J, Lok E, Swanson KD, Gautam S, Wong ET. Literature Review of Spinal Cord Glioblastoma. Am J Clin Oncol. 2018 12; 41(12):1281-1287.
Lok E, Swanson KD, Wong ET. Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations. Expert Rev Med Devices. 2015; 12(6):717-26.
Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD. Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269.
Lok E, Chung AS, Swanson KD, Wong ET. Melanoma brain metastasis globally reconfigures chemokine and cytokine profiles in patient cerebrospinal fluid. Melanoma Res. 2014 Apr; 24(2):120-30.
Wong ET, Lok E, Swanson KD, Gautam S, Engelhard HH, Lieberman F, Taillibert S, Ram Z, Villano JL. Response assessment of NovoTTF-100A versus best physician's choice chemotherapy in recurrent glioblastoma. Cancer Med. 2014 Jun; 3(3):592-602.
Locasale JW, Melman T, Song S, Yang X, Swanson KD, Cantley LC, Wong ET, Asara JM. Metabolomics of human cerebrospinal fluid identifies signatures of malignant glioma. Mol Cell Proteomics. 2012 Jun; 11(6):M111.014688.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.